Clinical evaluation of teicoplanin fluorescence polarization immunoassay.
A teicoplanin fluorescence polarization immunoassay (FPIA) developed by International BioClinical (IBC) was evaluated by using serum samples from patients who had been receiving teicoplanin at Detroit Receiving Hospital (DRH) as part of a clinical investigation. Patient samples collected over a 1-ye...
Spremljeno u:
| Izdano u: | Antimicrob Agents Chemother |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1991
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245223/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1834014/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.8.1586 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
